IBUY
🇦🇺 ASX
👑 Overview
📈 Performance
📙 Holdings
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-7.61%
Annual Growth
3 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
IBUY.AX was created on 2022-02-14 by BetaShares. The fund's investment portfolio concentrates primarily on consumer discretionary equity. IBUY.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to a portfolio of the worlds leading online retailers.
📈 Performance
Price History
-23.91%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
TENCENT HOLDINGS LTD
5.55%
ALIBABA GROUP HOLDING LTD
5.45%
MEITUAN
5.16%
Updated as of 13 May 2023
Industry Exposure
🛍️ Consumer
54%
📞 Communication
19%
🏭 Industrials
10%
📙 Other
7%
🤖 Information
5%
🏦 Financials
5%
Country Exposure
🇺🇸 United States of America (the)
48%
🇨🇳 China
17%
🇰🇾 Cayman Islands (the)
6%
🇮🇪 Ireland
5%
🇨🇦 Canada
5%
🇳🇱 Netherlands (the)
4%
🇺🇾 Uruguay
4%
🇸🇬 Singapore
3%
🇱🇺 Luxembourg
2%
🇩🇪 Germany
2%
🇯🇵 Japan
1%
🇬🇧 United Kingdom of Great Britain and Northern Ireland (the)
1%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$9.39
💰 Price To Earnings Ratio
30.73
💰 Price To Book Ratio
4.70
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IBUY
5
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in IBUY
699 days
IBUY investor breakdown
💵 Income of investors
More than 200k
150k - 200k
20%
100k - 150k
20%
50k - 100k
40%
Less than 50k
20%
👶 Age of investors
18 - 25
26 - 34
40%
35 - 90
60%
🙋 Legal gender of investors
Female
80%
Male
20%
Pearlers who invest in IBUY also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
📊 Share price
$43.11 AUD
NULL US
NULL EX AUSTRALIA
NULL BETA
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
📊 Share price
$73.26 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL EX AUSTRALIA
Want more shares? Try these...
Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-06-22. The Company’s principal activity consists of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using superparamagnetic relaxometry. The firm operates through Research and Development segment. Its MagSense technology is a functional imaging agent for detecting cancers and other critical diseases. MagSense technology uses bio-safe magnetic nanoparticles that are cancer-specific. MagSense nanoparticles are specially formulated as an injectable solution for each type of cancer. MagSense applications include breast cancer, prostate cancer, and ovarian cancer. The firm is conducting a Phase I clinical study of its MagSense HER2 imaging agent. Its PrecisionMRX nanoparticles have been developed for magnetic relaxometry and other demanding biomedical applications. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.
📊 Share price
